Phase 1 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have higher-than-normal levels of LDL cholesterol (sometimes called "bad" cholesterol) in their blood, whether or not they are currently taking medication to lower it
- People who are willing and able to agree to participate before any study activities begin, and who are able to follow all study procedures throughout the trial
Who may not be able to join:
- People who have had a heart attack, stroke, or similar cardiovascular event within the last 6 months
- People who have any serious or uncontrolled health condition, or who have had a medical or surgical issue that could interfere with taking part in the study
- People who have been diagnosed with familial hypercholesterolaemia, which is an inherited condition that causes very high cholesterol levels from birth
- People who currently have, or have a history of, liver disease
- People who have previously been treated with a type of cholesterol-lowering medication called a PCSK9 inhibitor, or certain other treatments within a specific time period before the trial (confirm with trial site for exact timeframes)
- People whose blood test results show certain abnormal values that are considered clinically significant (confirm with trial site for specific details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stephen Nicholls, MBBS, FRACP, PhD, VHI
Phone: +61 423245187
Australian sites
+61 3 7511 1252
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence and Severity of Treatment-Emergent Adverse Events (TEAEs); Incidence and Severity of Serious Adverse Events (SAEs); Incidence and Severity of Adverse Events of Special Interest (AESI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.